DailySand tracks leucovorin across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where leucovorin appears in today's cross-sector intelligence briefing.
1 item across 1 digest
March 10, 2026
FDA approves leucovorin as the first drug treatment for a rare genetic disorder, following previous promotion by the Trump administration as a potential autism therapy. This regulatory approval could establish a precedent for broader neurological applications and represents a significant milestone in rare disease treatment development.
Read original →
DailySand